Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NNMT | P40261 | 1/20 | 0.56 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.55 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20097214 | 0.93 | TRPM2 (0.59) | TRPM2DOT1L | |
| SCHEMBL20097210 | 0.90 | NNMT (0.60) | NNMTTRPM2DOT1L | |
| SCHEMBL20097122 | 0.88 | DOT1L (0.54) | TRPM2DOT1L | |
| SCHEMBL20097125 | 0.88 | DOT1L (0.55) | TRPM2DOT1L | |
| SCHEMBL20097130 | 0.85 | DOT1L (0.51) | TRPM2DOT1L | |
| SCHEMBL21311402 | 0.82 | DOT1L (0.65) | TRPM2DOT1L | |
| SCHEMBL20097129 | 0.81 | DOT1L (0.58) | TRPM2DOT1L | |
| SCHEMBL21311403 | 0.81 | DOT1L (0.60) | TRPM2DOT1L | |
| SCHEMBL20096932 | 0.81 | DOT1L (0.71) | NNMTDOT1L | |
| SCHEMBL13773226 | 0.79 | TRPM2 (0.81) | TRPM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190262371-A1 | METHODS AND COMPOSITION FOR THE TREATMENT OF RNA VIRAL INFECTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-08-29 | — | — | US | disclosed |
| WO-2018075947-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF RNA VIRAL INFECTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190262371-A1 | METHODS AND COMPOSITION FOR THE TREATMENT OF RNA VIRAL INFECTIONS | POLRMT, EIF2AK2, NSUN3 | NNMT 865/4885TRPM2 4610/4885DOT1L 2274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.